Clinical Trial Detail

NCT ID NCT04272645
Title Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer
Recruitment Withdrawn
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Rogel Cancer Center
Indications

prostate adenocarcinoma

Therapies

Abemaciclib + Atezolizumab

Abemaciclib

Atezolizumab

Age Groups: adult senior

No variant requirements are available.